Telos Capital Management Inc. cut its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 5.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 17,055 shares of the financial services provider’s stock after selling 1,027 shares during the period. Telos Capital Management Inc.’s holdings in Aflac were worth $1,407,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BKM Wealth Management LLC acquired a new stake in Aflac during the 4th quarter valued at $1,558,000. Nordea Investment Management AB raised its position in shares of Aflac by 25.9% in the 4th quarter. Nordea Investment Management AB now owns 1,693,249 shares of the financial services provider’s stock worth $139,676,000 after buying an additional 348,400 shares during the period. G&S Capital LLC raised its position in shares of Aflac by 65.1% in the 4th quarter. G&S Capital LLC now owns 31,825 shares of the financial services provider’s stock worth $2,626,000 after buying an additional 12,551 shares during the period. DekaBank Deutsche Girozentrale raised its position in shares of Aflac by 7.5% in the 4th quarter. DekaBank Deutsche Girozentrale now owns 376,087 shares of the financial services provider’s stock worth $30,786,000 after buying an additional 26,338 shares during the period. Finally, Kestra Private Wealth Services LLC raised its position in shares of Aflac by 12.7% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 48,745 shares of the financial services provider’s stock worth $3,741,000 after buying an additional 5,477 shares during the period. 67.44% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the transaction, the director now directly owns 17,920 shares in the company, valued at $1,516,390.40. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the sale, the director now owns 17,920 shares of the company’s stock, valued at $1,516,390.40. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Masatoshi Koide sold 30,493 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the transaction, the director now owns 86,090 shares in the company, valued at approximately $6,879,451.90. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 46,493 shares of company stock worth $3,765,706. Corporate insiders own 0.90% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on AFL
Aflac Price Performance
Shares of NYSE AFL opened at $80.26 on Thursday. The stock has a market capitalization of $46.18 billion, a price-to-earnings ratio of 10.36, a PEG ratio of 2.21 and a beta of 0.91. The business has a 50-day moving average of $82.06 and a 200-day moving average of $81.46. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.06 and a quick ratio of 0.06. Aflac Incorporated has a fifty-two week low of $64.10 and a fifty-two week high of $86.26.
Aflac (NYSE:AFL – Get Free Report) last posted its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a return on equity of 17.59% and a net margin of 24.92%. The business had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $4.44 billion. During the same quarter in the previous year, the business posted $1.29 EPS. As a group, sell-side analysts predict that Aflac Incorporated will post 6.41 earnings per share for the current fiscal year.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- Most Volatile Stocks, What Investors Need to Know
- What’s Driving Tesla Lower Ahead of its Earnings?
- Learn Technical Analysis Skills to Master the Stock Market
- Here are the Pros and Cons of Using Options Put Credit Spreads
- What Does Downgrade Mean in Investing?
- Can Netflix Stock Continue Into All-Time Highs After Earnings?
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.